Suchergebnisse - "Burger, David M"

PubPharm (27)

1

Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir : A Validation and Pharmacokinetic Simulation Study

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Hermans, L. | Nijhuis, M. | Tempelman, H. | +5

2

Carbamazepine intervention in a patient with efavirenz-induced liver injury

enthalten in: AIDS (London, England) | 2019

von Jacobs, T. | Burger, D. | Pranger, A. | +3

3

Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents

enthalten in: Antiviral therapy | 2018

von Jantarabenjakul, W. | Anugulruengkitt, S. | Kasipong, N. | +10

4

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

enthalten in: Clinical pharmacokinetics | 2018

von Schalkwijk, S. | Ter Heine, R. | Colbers, A. | +10

5

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2017

von Avihingsanon, A. | Maek-A-Nantawat, W. | Gatechompol, S. | +7

6

Rethinking the risk-benefit ratio of efavirenz in HIV-infected children

enthalten in: The Lancet. Infectious diseases | 2016

von Van de Wijer, L. | Schellekens, A. | Burger, D. | +3

7

Efavirenz and risk of suicide in HIV patients

enthalten in: Nederlands tijdschrift voor geneeskunde | 2015

von Burger, D. | de Mast, Q. | Schellekens, A.

CommentOn: Ann Intern Med. 2014 Jul 1;161(1):1-10. - PMID 24979445

8

Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients : a pharmacokinetic and safety study

enthalten in: Antiviral therapy | 2013

von Semvua, H. | Mtabho, C. | Fillekes, Q. | +10

9

Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda : treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2012

von Mutwa, P. | Fillekes, Q. | Malgaz, M. | +7

10

Pediatric underdosing of efavirenz : a pharmacokinetic study in Uganda

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2011

von Fillekes, Q. | Natukunda, E. | Balungi, J. | +86